Accreditation Statements

WORLDSymposium™ Ethical MedTech EU Compliance


EthicalMedTech is a platform, supported by MedTech Europe, dedicated to ethics and compliance projects in the European MedTech industry.

WORLDSymposium has been assessed Compliant for the 2026 Scientific Meeting. Details are posted on www.ethicalmedtech.eu.

WORLDSymposium 2021, 2022, 2023, 2024 and 2025 were also found to be compliant in accordance with the principles and standards set out in the MedTech Europe Code of Ethical Business Practice.

WORLDSymposium 2026 Genetic Counselor CEUs

The National Society of Genetic Counselors (NSGC) has authorized WORLDSymposia, LLC  to offer up to 2.3 CEUs or 23 Category 1 contact hours for the activity 22nd Annual WORLDSymposium 2026.The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor recertification.

  • WORLDSymposium 2026 – 20.8 contact hours (2.08 CEUs)
  • Patient Voice 2026 – 1.0 contact hours (0.1 CEUs)
  • 5th Annual Gorlin Symposium – 1.2 contact hours (0.12 CEUs)

NSGC credit will be available to Live attendees only. CEUs for Genetic Counselors do not apply for the On Demand program.

Genetic Counselors must complete an online evaluation. Instructions will be provided in the mobile app. The online evaluation should be completed within 2 weeks post-conference, and must include your NSGC number. Please note, you are required to pay the NSGC Fee of $35 at the time of registration in order to obtain NSGC Credit; if you did not pay the fee, you may not receive the NSGC CEU Credits. Upon completion of the online Evaluation, you will receive a Certificate of Completion. The official Certificate of Credit will come directly from NSGC. If you have any questions, contact Angela Meader at: angela@worldsymposia.org.

2026 ACCME & ANCC Accreditation

WORLDSymposium 2026 is jointly provided by Medical Education Resources and WORLDSymposium. CE credit is available to Live and On Demand attendees. 

Program Overview:
The goal of WORLDSymposium is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposium hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases. This symposium is designed to help researchers, clinicians, registered nurses, and genetic counselors better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.

Target Audience:
This activity is intended for healthcare professionals involved in the screening, diagnosis, management, and treatment of lysosomal diseases affecting both children and adults, with research and clinically relevant information geared specifically to the following professionals:

  • Medical and clinical geneticists; genetic counselors; pediatricians; neurologists; psychologists; nurse practitioners; physician associates; registered nurses; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, lysosomal diseases.
  • Laboratory directors and technicians involved in genetic testing.
  • Researchers involved in lysosomal disorders and treatments.
  • Clinical, laboratory and research trainees of genetics and all biomedical sciences with a focus on lysosomal diseases.
  • Any healthcare and public health professionals who have an interest in medical and clinical genetics and genomics in the area of lysosomal diseases.
  • Advocates for patients with lysosomal diseases and their families.

NOTE: Adult patients and adult family members are welcome to attend the educational sessions, however the content is intended for clinicians and researchers, and not targeted toward patients. Attendance for patients and family members is offered as an opportunity to obtain information pertinent to their personal journey and to connect with leading researchers and clinicians. Children under 18 are not allowed in any session.

Educational Objectives:
At the completion of this program, the participant should be able to:

  • Identify the key diagnostic features of lysosomal diseases.
  • Utilize recent diagnostic tests for lysosomal diseases.
  • Compare the relative advantages and disadvantages of each therapy currently available.
  • Identify unmet needs of each disease being discussed.
  • Formulate new research ideas for these lysosomal diseases.

Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources and WORLDSymposium. Medical Education Resources is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional Continuing Education (IPCE):

This activity was planned by and for the healthcare team, and learners will receive 15.0 Interprofessional continuing Education (IPCE) credit for learning and change.

Physician Credit:
Medical Education Resources designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit:
Medical Education Resources designates this live activity for a maximum of 15.0 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 15.0 contact hours.

Disclosure of Relevant Financial Relationships:
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

Americans with Disabilities Act:

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Amanda Thomas prior to the live event at athomas@etherio.com